Medeon Biodesign (Taiwan) Analysis
| 6499 Stock | TWD 40.00 0.40 1.01% |
Medeon Biodesign is fairly valued with Real Value of 38.8 and Hype Value of 40.0. The main objective of Medeon Biodesign stock analysis is to determine its intrinsic value, which is an estimate of what Medeon Biodesign is worth, separate from its market price. There are two main types of Medeon Biodesign's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Medeon Biodesign's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Medeon Biodesign's stock to identify patterns and trends that may indicate its future price movements.
The Medeon Biodesign stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Medeon Biodesign is usually not traded on No Trading . Market opens only for Clearing & Settlement 2, Adjusted Holiday / Chinese New Year 's Eve, Chinese New Year 's Eve, Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2, Mid - autumn / Moon Festival. Medeon Stock trading window is adjusted to Asia/Taipei timezone.
Medeon |
Medeon Stock Analysis Notes
About 50.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.29. In the past many companies with similar price-to-book ratios have beat the market. Medeon Biodesign recorded earning per share (EPS) of 30.41. The entity last dividend was issued on the 22nd of August 2022. The firm had 1000:1049 split on the 22nd of August 2023. For more info on Medeon Biodesign please contact YueTeh Jang at 886 2 2881 6686 or go to https://www.medeonbio.com.Medeon Biodesign Investment Alerts
| Medeon Biodesign generated a negative expected return over the last 90 days | |
| Medeon Biodesign has high likelihood to experience some financial distress in the next 2 years | |
| Medeon Biodesign generates negative cash flow from operations | |
| About 50.0% of the company shares are owned by insiders or employees |
Medeon Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medeon Biodesign's market, we take the total number of its shares issued and multiply it by Medeon Biodesign's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Medeon Profitablity
Medeon Biodesign's profitability indicators refer to fundamental financial ratios that showcase Medeon Biodesign's ability to generate income relative to its revenue or operating costs. If, let's say, Medeon Biodesign is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Medeon Biodesign's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Medeon Biodesign's profitability requires more research than a typical breakdown of Medeon Biodesign's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.31) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.64. Technical Drivers
As of the 23rd of December, Medeon Biodesign secures the Mean Deviation of 1.06, risk adjusted performance of (0.07), and Standard Deviation of 1.61. Medeon Biodesign technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Medeon Biodesign coefficient of variation, variance, and the relationship between the mean deviation and standard deviation to decide if Medeon Biodesign is priced some-what accurately, providing market reflects its recent price of 40.0 per share.Medeon Biodesign Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Medeon Biodesign middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Medeon Biodesign. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Medeon Biodesign Outstanding Bonds
Medeon Biodesign issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medeon Biodesign uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medeon bonds can be classified according to their maturity, which is the date when Medeon Biodesign has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Medeon Biodesign Predictive Daily Indicators
Medeon Biodesign intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medeon Biodesign stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Medeon Biodesign Forecast Models
Medeon Biodesign's time-series forecasting models are one of many Medeon Biodesign's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medeon Biodesign's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Medeon Biodesign to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Additional Tools for Medeon Stock Analysis
When running Medeon Biodesign's price analysis, check to measure Medeon Biodesign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medeon Biodesign is operating at the current time. Most of Medeon Biodesign's value examination focuses on studying past and present price action to predict the probability of Medeon Biodesign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medeon Biodesign's price. Additionally, you may evaluate how the addition of Medeon Biodesign to your portfolios can decrease your overall portfolio volatility.